6-138846650-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001077706.3(ECT2L):āc.876A>Cā(p.Leu292Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000666 in 1,607,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001077706.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ECT2L | NM_001077706.3 | c.876A>C | p.Leu292Phe | missense_variant | 8/22 | ENST00000541398.7 | NP_001071174.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ECT2L | ENST00000541398.7 | c.876A>C | p.Leu292Phe | missense_variant | 8/22 | 5 | NM_001077706.3 | ENSP00000442307 | P1 | |
ECT2L | ENST00000367682.6 | c.876A>C | p.Leu292Phe | missense_variant | 7/21 | 5 | ENSP00000356655 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152170Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000738 AC: 18AN: 243812Hom.: 0 AF XY: 0.0000453 AC XY: 6AN XY: 132406
GnomAD4 exome AF: 0.0000385 AC: 56AN: 1454786Hom.: 0 Cov.: 31 AF XY: 0.0000207 AC XY: 15AN XY: 723616
GnomAD4 genome AF: 0.000335 AC: 51AN: 152288Hom.: 0 Cov.: 30 AF XY: 0.000336 AC XY: 25AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.876A>C (p.L292F) alteration is located in exon 8 (coding exon 6) of the ECT2L gene. This alteration results from a A to C substitution at nucleotide position 876, causing the leucine (L) at amino acid position 292 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at